Picture of Transense Technologies logo

TRT Transense Technologies News Story

0.000.00%
gb flag iconLast trade - 00:00
Consumer CyclicalsSpeculativeMicro CapContrarian

REG - Transense Technlgy - Interim Results

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260217:nRSQ2397Ta&default-theme=true

RNS Number : 2397T  Transense Technologies PLC  17 February 2026

The information contained within this announcement is deemed by the Company to
constitute inside information pursuant to Article 7 of EU Regulation 596/2014
as it forms part of UK domestic law by virtue of the European Union
(Withdrawal) Act 2018 as amended.

 

17 February 2026

Transense Technologies plc

("Transense" or the "Company")

 

Interim Results & Investor Presentation

 

Transense Technologies plc, a leading provider of specialist sensing solutions
and measurement systems, reports its unaudited Interim Results for the six
months ended 31 December 2025.  The core trading divisions, SAWsense and
Translogik, continue to deliver solid revenue growth of 39% in the period.
Whilst this growth rate is below the previous market expectation, as set out
in the Company's announcement on 30 January, it reflects continued customer
demand and meaningful commercial progress.  The Company was cash generative
and delivered a small profit before tax in the first half, despite the
contractual reduction in Bridgestone iTrack royalty rates at the beginning of
the period.

The execution of the Company's strategy to develop scale and resilience at
SAWsense and Translogik is progressing well, and the pipeline of new business
opportunities across the Company's activities continues to build.

SAWsense highlights:

·    Revenue up 74% to £0.66m (FY25 H1: £0.38m)

·    Order book (excluding grant income) as at 31 December 2025 increased
to £0.55m (1 July 2025: £0.24m)

·    Increased funded support to GE on component supply for T901

·    Four customer-funded robotics development projects in progress

·    Total live projects stand at 23 with 17 contracted customers (up from
17 projects and 14 customers as at 1 July 2025)

Translogik highlights:

·    Revenue up 13% to £0.59m (FY25 H1: £0.52m)

·    Three hardware + SaaS subscription customers on-boarded in UK

·    Increased passenger car market penetration through software reseller
in France

·    UK fleet business building - new SDR consultancy appointed to
increase lead generation

·    TLGi smart inflation product launched, with additional product due
for launch in H2

·    Three further reseller partnerships in final stages of negotiation

·    EU regulation requiring digital passport for life cycle management a
key driver for adoption

 

Group financial summary:

·    Revenue (excluding Bridgestone iTrack royalty income) up 39% to
£1.25m (FY25 H1: £0.90m)

·    Total revenue reduced by 8% to £2.26m (FY25 H1: £2.46m)

·    Gross margin maintained at 90%

·    Profit before taxation slightly above break even (FY25 H1: £0. 55m)

·    Cash flow from operations of £0.41m (FY25 H1: £0.24m)

·    Available cash at 31 December 2025 was £1.33m (30 June 2025:
£1.14m), with subsequent increase to £1.77m at 31 January 2026 following
receipt of the quarterly royalty

·    Net cash of £0.92m at 31 December 2025 reflects the drawdown of
£0.40m of the £1.00m Asset Loan finance facility

 

Commenting on the results and prospects, Executive Chairman of Transense,
Nigel Rogers, said:

"Whilst our core operating businesses are continuing to deliver growth, lead
times to adoption and ramp up of new Translogik customers have been taking
longer than previously expected. Additional headwinds from adverse currency
movements within the reduced Bridgestone iTrack royalty income have also
impacted our short term trading outlook, as announced in January.

Our pipeline of opportunities continues to expand in both scale and quality
and we remain highly confident from our broader dealings with customers that
they continue to have a strong desire to adopt our products.

There has been frustration in the first half that orders have not materialised
faster but the board are convinced that the plan which has been adopted is the
correct one, and that the key to success lies in determined continued focus on
execution.  The Company is well funded and cash generation will improve as
orders build."

 

Investor Presentation: 4pm today, Tuesday  17 February 2026

Nigel Rogers (Executive Chairman), Ryan Maughan (Managing Director) and Melvyn
Segal (Chief Financial Officer) will provide a presentation on the Company and
its Interim Results at 4pm today, Tuesday 17 February 2026. The presentation
will be hosted through the digital platform Investor Meet Company.

To attend the presentation, investors can sign up to Investor Meet Company for
free and select to meet Transense Technologies plc via the following link:
https://www.investormeetcompany.com/transense-technologies-plc/register-investor
(https://www.investormeetcompany.com/transense-technologies-plc/register-investor)
. Investors who have already registered and selected to meet the Company will
automatically be invited to the presentation.

Questions can be submitted before the event to
investor.relations@transense.co.uk (mailto:investor.relations@transense.co.uk)
or in real time during the presentation via the "Ask a Question" function.

This Interim Results report will not be posted to shareholders but will be
available on the Company's website later today along with the investor
presentation.

 

 

 

For further information please visit www.transense.com or contact:

 Transense Technologies plc                                       Via Investor Relations

 Nigel Rogers (Executive Chairman)                                (see below)

 Ryan Maughan (Managing Director)

 Melvyn Segal (Chief Financial Officer)
 Cavendish Capital Market Limited (Nominated Adviser and Broker)  0207 220 0500

 Adrian Hadden / Callum Davidson (Corporate Finance)

 Jasper Berry (Sales)
 Investor Relations                                               Tel: +44 (0)1869 238380

 Anice McNamee                                                    Investor.relations@transense.co.uk

 

 

Notes to Editors:

Transense is headquartered in Oxfordshire, UK and its shares are traded on
AIM, a market operated by the London Stock Exchange (AIM: TRT). The Company
develops and supplies advanced sensor technology and measurement solutions
used by some of the world's leading companies to improve performance,
efficiency, and safety in demanding, mission critical applications. Transense
currently operates through two active business segments:

 

SAWsense - designs, supplies and licences advanced sensor solutions based on
proven, patent protected Surface Acoustic Wave (SAW) technology to world
leading companies in aerospace, automotive, and industrial machinery
(including robotics), enabling improved efficiency and performance of their
products. Key customers include GE Aerospace, McLaren Applied, Airbus and
several other confidential Tier One automotive, aerospace and industrial
machinery suppliers.

 

Translogik - develops smart, connected commercial vehicle tyre inspection
equipment to many of the world's leading tyre suppliers, fleet operators and
service centres. Enabling accurate measurement and digital capture of
safety-critical tyre condition data, used to reduce operating costs, improve
safety and provide audit records for regulatory compliance. Key customers
include Bridgestone, Goodyear, Continental and Prometeon (Pirelli), and
leading independent providers of vehicle fleet maintenance management
software, and a growing list of international territory distribution partners.

 

In addition, Transense earns residual royalty income from Bridgestone iTrack -
a tyre monitoring system for off-highway vehicles that was developed by
Translogik. The associated sales, support and development infrastructure were
sold to Bridgestone Corporation, the world's largest tyre producer, in June
2020, and the intellectual property was licensed exclusively to Bridgestone
under a ten-year deal expiring in 2030.

 

Find out more at: https://www.transense.com/ (https://www.transense.com/)

 

Transense Technologies plc

Interim Results for the half year ended 31 December 2025

Chairman's statement

 

The financial results for the half year show robust revenue growth from our
core operating businesses, SAWsense and Translogik, almost offsetting the
expected reduction in the unit rate of royalty earned from Bridgestone iTrack
which took effect at the start of the year.  There has also been good
progress in the execution of our strategy to build both SAWsense and
Translogik into successful businesses capable of delivering sustainable high
growth at premium margin for many years, with significant investments now made
in our production processes and parts.

 

Business review

Surface Acoustic Wave (SAWsense)

Revenue increased by 74% to £0.66m (FY25 H1: £0.38m), with growth evident in
all four target market sectors and across each category of income.  The open
order book increased to £0.55m at the end of the period (£0.24m at 1 July
2025), with 23 funded projects from 17 customers on contract (17 and 14 at 1
July 2025).

Aerospace

The aerospace sector was again the largest revenue generator with growth at
around 50%, mostly from increased activity in component sales and supply chain
support to GE Aerospace for T901 production and next generation engine
development projects including HEAT and RISE.  Work is also advancing well on
the Aerospace Technology Institute supported LandOne program with Airbus for
sensors to be used in next generation landing gear in commercial aircraft.
In addition to this project, the Company has broadened its relationship with
Airbus, running additional commercial projects for them with more in the
pipeline.  Beyond GE and Airbus, the Company has active development projects
with other engine manufacturers and leading Tier 1 suppliers and a healthy
pipeline of new work.

The pace of funded development work in this sector reflects relatively
extended lead times into production - typically around ten years - however,
once designed in, this is balanced by long life cycle recurring revenues and
low risk of displacement.  There are currently 8 funded development projects
with 5 customers on contract, each expected to generate between £1m-£5m of
production revenue by 2032-2035.  There are a further 6 potential customers
engaged in active discussion which may lead to future funded development work.

Motorsport

Our commercial activities in motorsport are channelled through a close
partnership with Motion Applied (formerly McLaren Applied) who are well
positioned to provide market access with their excellent network and
reputation amongst major motorsport championships and race teams.  Revenues
in the period delivered strong growth over the same period last year, with new
requirements for additional professional motorsport championships to those in
IndyCar and World Endurance Championship.  There are further plans to expand,
with potential to extend the use cases between compliance (balance of
performance) and race teams (optimisation of performance), and from clutch
shaft output to main driveshaft applications.

Each motorsport application provides revenue potential of between
£0.2m-£0.5m, and further new business is expected in the next two years.

 

 

Electric motors and drives (EMD)

There are active commercial development projects with automotive customers for
hi-performance passenger cars, medium duty commercial vehicles, and
electrified commercial trailers, all due for production launch before 2030.
SAW technology has been successfully tested in customer applications showing
its ability to measure torque, forces and temperatures in production systems,
enabling system performance, cost and functional safety improvements. In
addition, prototypes are under development for an e-drive for a premium value,
high volume consumer product with a US customer due for launch in FY28.  In
total there are currently 7 funded development projects with 7 customers on
contract, each expected to generate between £3m-£5m of production revenue by
2028-2030.  There are a further 8 potential customers engaged in active
discussion which may lead to future funded development work.

 

Industrial Machinery & Robotics

The market for industrial and collaborative robots is fast moving and
characterised by ambitious companies looking for innovations to deliver a
competitive edge in performance, reliability and cost.  From an initial
approach to this sector in 2024, the relatively rapid success in attracting
customer interest demonstrates that SAWsense technology can fulfil these
criteria given its capabilities in improved sensitivity, accuracy and
reliability, and the compact lightweight sensor package size required.

Four customer funded development programs are currently in progress, three of
which are with recognised global market leaders and one with an innovative
European start-up.   These are each expected to generate between £2m-£10m
of production revenue by 2028-2030.

Behind these opportunities, earlier stage discussions are underway with five
further well-established robotics specialists and one industrial machinery
tier 1 to scope potential development work.

Our internal development work on production equipment, parts and processes for
e-drive clients provide a direct read-across into this sector, where
production volumes and target pricing is very similar.

 

 

Investment in production processes and parts

In late 2024, the Board approved approximately £2.8m in capital expenditure
over a 12-18 month period to build a pilot production line at Weston and
source updated versions of key components.

Expenditure to date on production equipment, scheduled to cost approximately
£1.25m, is on budget and has totalled £0.8m.  A further £0.4m is
anticipated to complete the investment.   Out of this total investment,
£1.0m is eligible for asset-backed loan financing, of which £0.4m was drawn
down at the end of the period and the balance is expected to be drawn down in
the second half of the year.

The major elements of the pilot production line are now on-site and
operational with delivery of the final item of production equipment, the die
bonding station used to place sensing elements onto shafts, due on site this
month.  The completed line will deliver increasing volumes for motorsport and
other initial production projects and provide assurance to high volume
customers for validation of parts and processes.

The development of the next generation ASIC is progressing well, with the
first prototype units currently being packaged and testing planned to commence
this month.  The design of a new current sensing element (AQP) and associated
supply chain is secured.  Work has also commenced looking into size and cost
reduction opportunities for the future, as well as new sensing elements to
complement enhanced functionality of next generation ASIC.  The total
investment in origination of next generation components to support high volume
production in future has been approximately £0.9m to date and a further
£0.7m of expenditure to complete is anticipated over the remainder of FY26
and FY27.

 

Translogik

Revenue grew by 13% to £0.59m (FY25 H1: £0.52m), despite a 24% reduction in
sales to the established customer base of global tyre majors to £0.25m from
£0.32m.   This reduction reflects difficult market conditions for these
companies, with challenger low-cost competitors entering mature geographical
markets despite the mitigating effect of tariffs and other trade barriers.

The adoption of a multi-channel sales approach is proving effective.  Growth
was delivered through the conversion of direct sales to end-users such as
fleet operators and service providers, through resale by software suppliers,
and via overseas distribution.

Following a change in sales management at the start of the period, the focus
has been on building a pipeline of larger customer accounts, to improve
visibility as well as add scale.  Results have been positive, with a strong
prospects pipeline at the period end from almost a standing start.  This
activity has also recently been augmented by the appointment of an external
consultancy for Sales Development Representation (SDR) to generate more
qualified leads through outbound prospecting, with promising initial results.

The strategy for Translogik also includes increasing the breadth of the
product range and service offer through the development of complementary
hardware, and additional partnerships for software integration.  Good
progress has been made in both of these areas; in November the new smart
inflator range (TLGi) was launched for which sales will commence in the second
half of the year, and discussions are at an advanced stage to enter into three
further reseller agreements.

 

Bridgestone iTrack royalty income

Royalty income from Bridgestone iTrack was £1.01m; a reduction of 35%
(FY25H1: £1.56m).

As previously noted, the royalty rate per installation decreased by 40% from 1
July 2025.  The effect of this reduction was exacerbated by a headwind on the
conversion of US dollar income of around 5%.  This was, however, offset by
approximately 10% volume growth in the number of installations during the
period, resulting in the overall 35% reduction year-on-year.  This was
somewhat below previous guidance, which had anticipated 15% volume growth and
a neutral effect of foreign exchange resulting in an overall 25% reduction.
The outlook for additional installations in the second half of the year and
into FY27 remains positive.

 

Financial review

Financial results

Revenues for the six months reduced by £0.20m to £2.26m (FY25 H1: £2.46m),
with revenues excluding Bridgestone iTrack royalty up 39% to £1.25m (FY25 H1:
£0.90m).  Gross margin was maintained at 90% of revenue (FY25 H1: 90%).
  Revenues (excluding Royalty income) continued to be generated across a
global marketplace, with 79% arising from non-UK sources (FY25 H1: 89%).

The royalty rate reduction of 40% saw income from iTrack reduce by 35% to
£1.01m (FY25 H1: £1.56m). Since inception the installed base has increased
nearly sixfold, and as a result of the increased installed base the impact of
the rate reduction has been tempered and the current years royalty income is
tracking the rate in FY23.

Revenues for SAWsense (including Grant income) and Translogik have each seen
year on year increases of 74% and 13% respectively, with SAWsense generating
£0.66m (FY25 H1: £0.38m) and Translogik  generating £0.59m (FY25 H1:
£0.52m).

Planned increases in operating costs brought the total to £2.04m, compared
with £1.66m in the corresponding period last year.  As in the previous year,
this increase is primarily reflected in additional personnel costs associated
with building out the engineering, commercial and operational capabilities
needed to deliver revenue growth.

At a segmental level, the net contribution from SAWsense (negative) and
Translogik have both registered improvements on the corresponding period with
SAWsense reducing its loss by £0.08m and Translogik increasing its
contribution by £0.10m. These positive changes reflect the increased
investment in both segments leading to material increases in pipeline
opportunities for SAWsense and better opportunities and margins for
Translogik. The Board's plan to offset the reduction in royalty income with
increased contributions from both SAWsense and Translogik is now underway,
although the pace is slightly slower than previously anticipated in guidance
early last year.

 

Key performance indicators (KPI)

The Board considers the following to be the key performance indicators for the
Company:

 

                                              FY 2026       FY 2025
                                              Interim       Interim       Full Year

                                              (unaudited)   (unaudited)   (audited)
 Revenue (£m)                                 2.26          2.46          5.55
 iTrack royalty run rate growth YoY (in USD)  -35%          24%           26%
 Translogik revenue growth YoY                13%           7%            18%
 SAW revenue growth YoY                       74%           361%          148%
 Revenue from non-UK sources                  79%           89%           92%
 Gross Margin (% of revenue) - blended        90%           90%           90%

 Gross Margin (% of revenue) - excl iTrack    83%           72%           77%

 Net Operating Margin (% of revenue)          0%            22%           25%
 AEBITDA (£m)                                 0.33          0.80          1.96
 EPS (pence)                                  0.02          3.61          9.25
 Available cash balances (£m)                 1.33          1.19          1.14
 Distributable reserves (£m)                  4.85          3.99          4.85
 Average share price in period (pence)        128.6         160.0         150.6

 

Cash flow and financial position

Net cash inflow from operating activities was £0.41m, ahead of the same
period last year (FY25 H1: £0.24m), partly as a result of the reduced working
capital requirement.  The investment in capital expenditure continued with a
spend in the period of £0.56m (FY25 H1: £0.28m).

Available cash balances at the end of the period stood at £1.33m (30 June
2025: £1.14m). As previously indicated the Company arranged asset loan
finance of £1.00m to support the planned spend on plant, machinery and
equipment. In December 2025, reflecting completion of some of the proposed
spend, the Company drew down £0.41m of the facility resulting in the net cash
balance at the end of December 2025 of £0.92m. The available cash balance at
the end of January stood at £1.77m following receipt of the December 2025
quarter royalties.

The Board has assessed the financial and operational needs of the business
over the next twelve months, taking into account a range of contingencies, and
the Directors are satisfied that the Company has access to adequate sources of
finance. Accordingly, the Board considers that the Company will have
sufficient resources to continue in operational existence for the foreseeable
future, and has adopted the going concern basis of accounting.

The planned spend on capital expenditure is ongoing and the spend on tangible
assets up to £0.59m will be financed in H2 of this financial year. There also
remains expenditure on R & D to secure the supply chain and this is
estimated at £0.7m over the next 18 months.

 

Outlook

 

Pipeline opportunities in both SAWsense and Translogik continue to expand in
scale and quality and we reman highly confident from our broader dealings with
customers that they continue to have a strong desire to adopt our products.

The board are satisfied that the plan which has been implemented consistently
is still well-grounded, and that the key to success lies in determined
continued focus on execution.

 

Nigel Rogers

Executive Chairman

17 February 2026

 

 

 

 

 Transense Technologies plc
 Condensed Statement of Comprehensive Income
                                                        Half year to    Half year to     Full year to
                                                        31 Dec 25       31 Dec 24        30 Jun 25
                                                        (Unaudited)     (Unaudited)      (Audited)
                                                        £'000           £'000            £'000
 Revenue                                                2,083           2,328            5,162
 Grant Revenue                                          179             131              388
 Total Revenue                                          2,262           2,459            5,550
 Cost of sales                                          (219)           (253)            (556)
 Gross profit                                           2,043           2,206            4,994
 Operating expenses                                     (2,034)         (1,659)

                                                                                         (3,586)

 Operating profit                                       9               547              1,408
 Financial (expense)/income                             (5)             3                -
 Profit before taxation                                 4               550              1,408
 Taxation                                               -               -                -
 Profit for the period from continuing operations       4               550              1,408

 

 

 

 Earnings per share (pence)  0.02    3.61      9.25

 

 Condensed Statement of Financial Position
                                             31 Dec 25             31 Dec 24             30 Jun 25
                                             (Unaudited)           (Unaudited)           (Audited)
                                             £'000                 £'000                 £'000
 Non current assets
 Property, plant and equipment               1,624                 945                         1,551
 Intangible assets                           2,409                 1,076                 2,118
 Deferred tax                                1,475                 1,475                 1,475
                                             5,508                 3,496                 5,144
 Current assets
 Inventory                                   324                   513                   377
 Trade and other receivables                 1,261                 1,629                 1,637
 Cash and cash equivalents                   1,327                 1,190                 1,138
                                             2,912                 3,332                 3,152
 Total assets                                8,420                 6,828                 8,296
 Current liabilities
 Trade and other payables                    (452)                 (281)                 (808)
 Bank Loan                                   (72)                  -                     -
 Lease liabilities                           (133)                 (100)                 (115)
 Total current liabilities                   (657)                 (381)                 (923)
 Non current liabilities
 Bank Loan                                   (339)                 -                     -
 Lease liabilities                           (239)                 (257)                 (252)
                                             (578)                 (257)                 (252)
  Total liabilities                          (1,235)                (638)                 (1,175)
 Net assets                                  7,185                 6,190                 7,121

 Capital and reserves
 Share capital                               1,644                 1,644                 1,644
 Share premium                               65                    65                    65
 Treasury Shares                             (1,027)               (1,027)               (1,027)
 Share based payments                        624                   491                   564
 Retained profit                             5,879                 5,017                 5,875
 Shareholders' funds                         7,185                 6,190                 7,121

 

 

 

               Transense Technologies plc
               Condensed Statement of Changes in Equity (Unaudited)

                                           Share capital  Share premium account  Share based payments  Retained earnings                    Total equity

                                                                                                                          Treasury Shares
                                           £'000          £'000                                        £'000              £'000             £'000

                                                                                 £'000
 Balance at 1 July 2024                    1,644          65                     418                   4,467              (1,027)           5,567
 Comprehensive income for the year:
 Profit for the year                       -              -                      -                     1,408              -                 1,408
 Share based payment                       -              -                      146                   -                  -                 146
 Treasury Shares                           -              -                      -                     -                  -                 -
 Balance at 30 June 2025                   1,644          65                     564                   5,875              (1,027)           7,121

 Comprehensive income for the period       -              -                      -                     4                  -                 4

 Profit for the period
 Share based payment                       -              -                      60                    -                  -                 60
 Treasury Shares                           -              -                      -                     -                  -                 -

 Balance at 31 December 2025               1,644          65                     624                   5,879              (1,027)           7,185

 

 

 Transense Technologies plc
 Condensed Statement of Cash Flows
                                                               Half year to    Half year to    Full year to
                                                               31 Dec 25       31 Dec 24       30 Jun 25
                                                               (Unaudited)     (Unaudited)     (Audited)
                                                               £'000           £'000           £'000
 Cash flow from operating activities
 Profit for the period                                         4               550             1,408
 Adjustments for:
 Net financial expense/(income)                                5               (3)                             -
 Depreciation of property, plant and equipment                 153             103             239
 Profit on sale of property,plant and equipment                -               -               (2)
 Amortisation and impairment of intangible assets              110             83              172
 Share based payments                                          60              73              146
 Operating cash flows before movements in working capital      332             806             1,963

 Change in receivables                                         376             (234)           (242)
 Change in payables                                            (356)           (212)           315
 Change in inventories                                         53              (123)           13
 Net cash (used)/generated in operations                       405             237             2,049

 Cash flows from investing activities
 Acquisition of property, plant & equipment                    (158)           (158)           (839)
 Acquisition of intangible assets                              (401)           (126)           (1,256)
 Proceeds from sale of property,plant and equipment            -               -               2
 Net cash used in investing activities                         (559)           (284)           (2,093)

 Cash flows from financing activities
 Interest                                                      (5)             3               -
 Asset financing loan                                          411             -               -
 Payment of lease liabilities                                  (63)            (47)            (99)
 Net cash (used)/generated for financing activities            343             (44)            (99)

 Net (decrease)/increase in cash and cash equivalents          189             (91)            (143)
 Cash and cash equivalents at beginning of period              1,138           1,281           1,281
 Cash and cash equivalents at end of period                    1,327           1,190           1,138

 

 

Notes to the Interim results for the six months to 31 December 2025

1.  Reporting Entity and Basis of Preparation

Transense Technologies plc ("the Company") is a company incorporated in the
United Kingdom under the Companies Act 2006. These condensed interim financial
statements are presented in pounds sterling, rounded to the nearest thousand.

 

The financial statements of the Group are available upon request from the
Company's registered office or at www.transense.com (http://www.transense.com)

2.  Going Concern

The Board has considered the financial position and future plans of the
Company and is satisfied that the Company will have adequate resources to
continue in operational existence for the foreseeable future. Accordingly,
these interim financial statements have been prepared on a going concern
basis.

3.  Accounting policies

The Condensed Financial Statements for the half yearly report for the six
months ended 31 December 2025 have been prepared using accounting policies and
methods of computation consistent with those set in Transense Technologies
plc's Annual Report and Financial Statements for the year ended 30 June
2025.  There has been no change to any accounting policy since the date of
that report.

4.  Segmental analysis

 

 Revenue by region   Half year      Half year to 31 Dec 24  Full year to 30 Jun 25

                     to 31 Dec 25
                     (Unaudited)    (Unaudited)             (Audited)
                     £'000          £'000                   £'000
 North America       392            167                     464
 South America       61             42                      121
 Australia           11             11                      4
 Europe              285            279                     514
 UK                  265            146                     323
 Rest of the World   59             127                     144
 Grant Income (UK)   179            132                     -
 Total               1,252          904                     1,570
 Bridgestone iTrack  1,010          1,555                   2,610

 

 Half Year to 31 December 2025   IT Royalties                  SAWsense                      Translogik                            Central                               Total

                                 £'000                         £'000                         £'000                                 £'000                                 £'000
 Sales                           1,010                         483                           590                                                   -                     2,083
 Grant income                    -                             179                           -                                     -                                     179
 Gross profit                    1,010                         631                           401                                                   -                     2,042
 Operating expenses              (22)                          (923)                                       (226)                               (863)                                 (2,034)
 Operating profit/(loss)         988                           (292)                         175                                   (863)                                 8
 Net financial income/(expense)  -                                         -                 -                                     (5)                                   (5)
 Taxation                        -                             -                                             -                     -                                     -
 Profit/(loss) for the year                   988                          (292)             175                                               (868)                     3

 

 Half Year to 31 December 2024  IT Royalties                    SAWsense                      Translogik                            Central                               Total

                                £'000                           £'000                         £'000                                 £'000                                 £'000
 Sales                          1,555                           383                           521                                                   -                     2,459
 Gross profit                   1,555                           365                           286                                                   -                     2,206
 Operating expenses             (22)                            (735)                                       (210)                               (692)                                 (1,659)
 Operating profit/(loss)        1,533                           (370)                         76                                    (692)                                 547
 Net financial income           -                               -                                             -                     3                                     3
 Taxation                       -                               -                                             -                     -                                     -
 Profit/(loss) for the year                  1,533                          (370)             76                                                (689)                     550

 

 Year to 30 June 2025        IT Royalties  SAWsense                  Translogik  Central                               Total

                             £'000         £'000                     £'000       £'000                                 £'000
 Sales                       3,114         726                       1,322                       -                     5,162
 Grant Income                -             388                       -           -                                     388
 Gross profit                3,114         1,061                     819                         -                     4,994
 Operating expenses          (44)          (1,518)                   (451)       (1,573)                               (3,586)
 Operating profit/(loss)     3,070         (457)                     368         (1,573)                               1,408
 Net financial income        -                         -             -           -                                     -
 Taxation                    -             -                         -           -                                     -
 Profit/(loss) for the year  3,070         (457)                     368         (1,573)                               1,408

Note:

Grant Income is included in Turnover in the segmental numbers and the actual
grant income for each period is on the face of the Condensed Statement of
Comprehensive Income.

 

5.  Corporation tax and deferred tax

The Company has approximately £19m of Corporation Tax losses which, subject
to agreement by HM Revenue and Customs, are available for offset against
future profits of the same trade. There is no expiry date for tax losses,
however, there is an annual restriction of £5m plus half of the surplus above
£5m.

Whilst the Company has moved into consistent profitability it was decided,
last year, to freeze the deferred tax asset at £1.475m. This policy will be
maintained for the foreseeable future and at the appropriate time based on
profitability the deferred asset will be released back to the profit and loss
account.

 

6.  Earnings per share

 

                                                  31 December 2025  31 December 2024  30 June        2025
                                                  Shares            Shares            Shares
 Weighted average number of shares in the period  15,219,884        15,219,884        15,219,884

 Basic and diluted Earnings per share             0.02p             3.61p             9.25p

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IR SFIFAMEMSESE



            Copyright 2019 Regulatory News Service, all rights reserved

Recent news on Transense Technologies

See all news